{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:44:49Z","timestamp":1791305089204,"version":"4.3.1"},"reference-count":31,"publisher":"Rockefeller University Press","issue":"13","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,15]]},"abstract":"<jats:p>Adult T cell leukemia\/lymphoma (ATLL) is an aggressive malignancy caused by human T cell lymphotropic virus type-I (HTLV-I) without curative treatment at present. To illuminate the pathogenesis of ATLL we performed whole transcriptome sequencing of purified ATLL patient samples and discovered recurrent somatic mutations in CCR4, encoding CC chemokine receptor 4. CCR4 mutations were detected in 14\/53 ATLL samples (26%) and consisted exclusively of nonsense or frameshift mutations that truncated the coding region at C329, Q330, or Y331 in the carboxy terminus. Functionally, the CCR4-Q330 nonsense isoform was gain-of-function because it increased cell migration toward the CCR4 ligands CCL17 and CCL22, in part by impairing receptor internalization. This mutant enhanced PI(3) kinase\/AKT activation after receptor engagement by CCL22 in ATLL cells and conferred a growth advantage in long-term in vitro cultures. These findings implicate somatic gain-of-function CCR4 mutations in the pathogenesis of ATLL and suggest that inhibition of CCR4 signaling might have therapeutic potential in this refractory malignancy.<\/jats:p>","DOI":"10.1084\/jem.20140987","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T05:20:04Z","timestamp":1418102404000},"page":"2497-2505","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":130,"title":["Gain-of-function <i>CCR4<\/i> mutations in adult T cell leukemia\/lymphoma"],"prefix":"10.1084","volume":"211","author":[{"given":"Masao","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Xiao","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn K.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Xu","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandan","family":"Yang","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"2023072602024639000_bib1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3&lt;319::AID-IJC4&gt;3.0.CO;2-B","article-title":"Evaluation of adult T-cell leukemia\/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan","volume":"85","author":"Arisawa","year":"2000","journal-title":"Int. J. Cancer."},{"key":"2023072602024639000_bib2","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood."},{"key":"2023072602024639000_bib3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/23495","article-title":"The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells","volume":"400","author":"Campbell","year":"1999","journal-title":"Nature."},{"key":"2023072602024639000_bib4","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood."},{"key":"2023072602024639000_bib5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.187","article-title":"The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom\u2019s Macroglobulinemia","author":"Cao","year":"2014","journal-title":"Leukemia."},{"key":"2023072602024639000_bib6","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1182\/blood-2010-04-277418","article-title":"Autocrine\/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia","volume":"116","author":"Chen","year":"2010","journal-title":"Blood."},{"key":"2023072602024639000_bib7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.4049\/jimmunol.172.3.1575","article-title":"E-selectin, thymus- and activation-regulated chemokine\/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system","volume":"172","author":"Chong","year":"2004","journal-title":"J. Immunol."},{"key":"2023072602024639000_bib8","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.4049\/jimmunol.172.12.7761","article-title":"Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis","volume":"172","author":"Cronshaw","year":"2004","journal-title":"J. Immunol."},{"key":"2023072602024639000_bib9","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.4049\/jimmunol.169.5.2303","article-title":"Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion","volume":"169","author":"D\u2019Ambrosio","year":"2002","journal-title":"J. Immunol."},{"key":"2023072602024639000_bib10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.0105-2896.2005.00226.x","article-title":"CXCR4 mutations in WHIM syndrome: a misguided immune system?","volume":"203","author":"Diaz","year":"2005","journal-title":"Immunol. Rev."},{"key":"2023072602024639000_bib11","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1182\/blood-2010-12-319467","article-title":"FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia\/lymphoma","volume":"118","author":"Elliott","year":"2011","journal-title":"Blood."},{"key":"2023072602024639000_bib12","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2023072602024639000_bib13","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2023072602024639000_bib14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood."},{"key":"2023072602024639000_bib15","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"2023072602024639000_bib16","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Res."},{"key":"2023072602024639000_bib17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"2023072602024639000_bib18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.exphem.2005.01.001","article-title":"Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome","volume":"33","author":"Kawai","year":"2005","journal-title":"Exp. Hematol."},{"key":"2023072602024639000_bib19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/cas.12167","article-title":"Clinical significance of CD163+ tumor-associated macrophages in patients with adult T-cell leukemia\/lymphoma","volume":"104","author":"Komohara","year":"2013","journal-title":"Cancer Sci."},{"key":"2023072602024639000_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1242\/jcs.115.3.455","article-title":"The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals","volume":"115","author":"Luttrell","year":"2002","journal-title":"J. Cell Sci."},{"key":"2023072602024639000_bib21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer."},{"key":"2023072602024639000_bib22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/17460441.2014.897324","article-title":"Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4","volume":"9","author":"Pease","year":"2014","journal-title":"Expert Opin Drug Discov."},{"key":"2023072602024639000_bib23","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","article-title":"C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma","volume":"123","author":"Roccaro","year":"2014","journal-title":"Blood."},{"key":"2023072602024639000_bib24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature."},{"key":"2023072602024639000_bib25","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1182\/blood-2014-01-550905","article-title":"Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia","volume":"123","author":"Treon","year":"2014","journal-title":"Blood."},{"key":"2023072602024639000_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1189\/jlb.69.5.785","article-title":"Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo","volume":"69","author":"Vissers","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"2023072602024639000_bib27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/1521-4141(200103)31:3&lt;812::AID-IMMU812&gt;3.0.CO;2-L","article-title":"Dendritic cells as a major source of macrophage-derived chemokine\/CCL22 in vitro and in vivo","volume":"31","author":"Vulcano","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"2023072602024639000_bib28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","article-title":"Molecular hallmarks of adult T cell leukemia","volume":"3","author":"Yamagishi","year":"2012","journal-title":"Front Microbiol."},{"key":"2023072602024639000_bib29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"2023072602024639000_bib30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10428190400007607","article-title":"Expression of CCR4 in adult T-cell leukemia","volume":"46","author":"Yoshie","year":"2005","journal-title":"Leuk. Lymphoma."},{"key":"2023072602024639000_bib31","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/211\/13\/2497\/1749349\/jem_20140987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/211\/13\/2497\/1749349\/jem_20140987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T02:03:12Z","timestamp":1690336992000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/211\/13\/2497\/41458\/Gain-of-function-CCR4-mutations-in-adult-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20140987","relation":{},"ISSN":["1540-9538","0022-1007"],"issn-type":[{"value":"1540-9538","type":"electronic"},{"value":"0022-1007","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,8]]}}}